dimarts, 25 de març del 2014

Israel's Medigus lands FDA win for new MUSE acid reflux treatment




Medigus wins FDA clearance for the next generation of its minimally invasive MUSE system for treating acid reflux through the mouth.





Israel-based Medigus lands FDA win for new MUSE acid reflux treatment

Israel-based Medigus (TLV:MDGS) won FDA clearance for the next generation of its MUSE technology, a minimally invasive technology for performing surgeries to treat acid reflux disease.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1gyb3ea

Cap comentari:

Publica un comentari a l'entrada